A non-interventional, prospective study with benralizumab

Trial Identifier: D3250R00124
Sponsor: AstraZeneca
Collaborator:
None
Start Date: July 2024
Primary Completion Date: July 2027
Study Completion Date: July 2027
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Ansbach, Germany
Germany Auerbach, Germany
Germany Berlin, Germany
Germany Cottbus, Germany
Germany D sseldorf, Germany
Germany Darmstadt, Germany
Germany Ehringshausen, Germany
Germany Essen, Germany
Germany Flensburg, Germany
Germany Frankfurt am Main, Germany
Germany Hamburg, Germany
Germany Heidelberg, Germany
Germany Itzehoe, Germany
Germany Jena, Germany
Germany L beck, Germany
Germany L neburg, Germany
Germany L rrach, Germany
Germany Leipzig, Germany
Germany Markkleeberg, Germany
Germany Papenburg, Germany
Germany Rostock, Germany
Germany Saalfeld, Germany
Germany W rzburg, Germany
Germany Wei enburg, Germany
Germany Wilhelmshaven, Germany